Literature DB >> 22881413

Pathogenesis of infantile hemangiomas.

Lily Changchien Uihlein1, Marilyn G Liang, John B Mulliken.   

Abstract

1.Review the key features of the life cycle of infantile hemangiomas.2.Highlight cellular and molecular pathways involved in hemangioma-genesis.3.Discuss theories that may account for hemangioma-genesis.In the past, it was believed that a mother's visual impressions or behavior during pregnancy caused the growth of infantile hemangioma in her unborn child. She might have had an excessive craving for strawberries, witnessed the slaughter of an animal, directly contacted human or animal blood, or mocked a child with a similar birthmark.1 This folklore began to slowly fade once hemangiomas were examined through the light microscope. In 1863, Virchow2 suggested that hemangiomas are composed of proliferating new blood vessels resulting from progressive irritation of tissue. In 1933, Laidlow and Murray3 proposed a phylogenetic origin for hemangiomas and hypothesized that hemangiomas are remnants of vascular tufts functioning as accessory lungs for primitive amphibia. Pack and Miller4 (1950) hypothesized that hemangiomas develop from embryonic islands of angioblastic cells that were isolated from the systemic vasculature during fetal development. Copyright 2012, SLACK Incorporated.

Entities:  

Mesh:

Year:  2012        PMID: 22881413     DOI: 10.3928/00904481-20120727-08

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


  3 in total

1.  Efficacy of low-dose 90Sr-90Y therapy combined with topical application of 0.5% timolol maleate solution for the treatment of superficial infantile hemangiomas.

Authors:  Hong-Jian Zhu; Qinghong Liu; Xiao-Li Deng; Yan-Xing Guan
Journal:  Exp Ther Med       Date:  2015-07-01       Impact factor: 2.447

2.  Infantile Hemangioma Originates From A Dysregulated But Not Fully Transformed Multipotent Stem Cell.

Authors:  Shaghayegh Harbi; Rong Wang; Michael Gregory; Nicole Hanson; Keith Kobylarz; Kamilah Ryan; Yan Deng; Peter Lopez; Luis Chiriboga; Paolo Mignatti
Journal:  Sci Rep       Date:  2016-10-27       Impact factor: 4.379

3.  Urea immunoliposome inhibits human vascular endothelial cell proliferation for hemangioma treatment.

Authors:  Zhiliang Wang; Jie Li; Xin Xu; Xianglong Duan; Gang Cao
Journal:  World J Surg Oncol       Date:  2013-11-23       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.